Meeting
2020 ASCO Virtual Scientific Program
Incidence of large granular lymphocytosis (LGL) in patients with late cytopenias after allogeneic blood or marrow transplantation (AlloBMT).
Authors
Marcus Messmer
Johns Hopkins University, Baltimore, MD
Marcus Messmer , Laura Wake , Hua-Ling Tsai , Richard J. Jones , Ravi Varadhan , Nina D. Wagner-Johnston
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Track
Hematologic Malignancies
Sub Track
Allogenic Stem Cell Transplantation
Citation
J Clin Oncol 38: 2020 (suppl; abstr 7544)
DOI
10.1200/JCO.2020.38.15_suppl.7544
Abstract #
7544
Poster Bd #
317
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Grade III-IV cytokine release syndrome is associated with inferior survival in patients undergoing haploidentical donor stem cell transplants.
First Author: Omar Albanyan
Poster
2013 ASCO Annual Meeting
Incidence of posttransplantation lymphoproliferative disorder (PTLD) following allogeneic blood or marrow transplantation (alloBMT) using post-transplantation cyclophosphamide (PT-Cy) for graft-versus-host disease (GVHD) prophylaxis.
First Author: Jennifer Ann Kanakry
Poster
2012 ASCO Annual Meeting
Allogeneic stem cell transplantation for patients over age 65 with acute myelogenous leukemia and myelodysplastic syndrome.
First Author: Henry Jacob Conter
Poster
2022 ASCO Annual Meeting
Non-myeloablative allogeneic blood or marrow transplantation (AlloBMT) with post-transplant cyclophosphamide (PTCy) for peripheral T-cell lymphoma (PTCL): Improved outcomes with peripheral blood (PB) allografts and increased total body irradiation (TBI) to 400 cGV.
First Author: Cole Harris Sterling